Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 819 results for "eli lilly"

EU regulators give Oct. 3 deadline to decide on Eli Lilly, Nov...

s Editor EU antitrust authorities will decide whether to clear Eli Lilly's (NYSE:LLY) $5.4B offer for Novartis (NYSE:NVS) by Oct. 3. The acquisition is part of several deals recently announced in the healthcare industry, and would create the ... Seeking Alpha, 1 hour ago
[x]  

69 images for eli lilly

American Banking News, 8 hours ago
Mideast Time, 4 days ago
BioSpace, 5 days ago
Jutia Group, 6 days ago
Jutia Group, 1 week ago
Yahoo! Finance, 1 week ago
Vineyard Gazette, 3 days ago
Drug Store News, 5 days ago
Jutia Group, 1 week ago
PR Newswire, 6 days ago
Lawyer Herald

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) and US pharma major Eli Lilly (NYSE: LLY) have failed in their attempt to overturn a combined $9 billion punitive damage award by a US jury for hiding cancer risks associated with their ...
 Pharma Letter22 hours ago Takeda, Lilly Lose Bid to Get $9 Billion Actos Award Thrown Out  Bloomberg3 days ago Takeda, Eli Lilly on the hook for $9B in damages for hiding cancer risk of diabetes drug  MedCity News2 days ago Judge Upholds $9 Billion Actos Damage Award Against Takeda, Lilly  Claims Journal2 days ago
[x]  

Potential Eli Lilly (LLY) Trade Has 1.63% Downside Protection

MarketIntelligenceCenter.comaEUR(TM)s patented algorithms have chosen the Nov. '14 $65.00 call for a couple of hedged-trading ideas on Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY). A traditional covered call on Eli Lilly ...
 Individual.com3 days ago Eli Lilly (LLY) Trading Near $61.43 Support Level  Individual.com6 days ago Eli Lilly (LLY) Showing Resistance Near $62.99  Individual.com1 week ago Eli Lilly (LLY) Trading Near $62.54 Resistance Level  PredictWallStreet1 week ago

Jardiance type 2 diabetes tablets ship to pharmacies

RIDGEFIELD, Conn., and INDIANAPOLIS Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have released Jardiance tablets (empagliflozin) to U.S. pharmacies. The companies said Tuesday that the type 2 diabetes treatment is now available ...
 Chain Drug Review4 days ago Lilly, Boehringer Say Jardiance Tablets For Type 2 Diabetes Available In U.S.  RTTNews.com6 days ago Lilly Diabetes Treatment Now Available  Inside INdiana Business5 days ago

Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned

Eli Lilly and Company ( LLY ) and partner Boehringer Ingelheim are facing an issue related to Jardiance (empagliflozin) in the UK. The National Institute for Health and Care Excellence ( NICE ) has requested for additional information to validate ...
 Yahoo! Finance2 days ago Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod  Yahoo! Finance1 week ago Eli Lilly Gets Tentative FDA Approval For Diabetes Drug  Bidness Etc1 week ago
[x]  

Next Resistance Level for Eli Lilly (LLY) is $63.22

Shares of Eli Lilly (NYSE:LLY) have bullishly opened above the pivot of $62.82 today and have reached the first resistance level of $63.01. Should the shares continue to rise, the resistance pivots of $63.22 and $63.62 will be
 Individual.com4 days ago Watch for Shares of Eli Lilly (LLY) to Approach Resistance at $61.67  Individual.com1 week ago

Eli Lilly and Boehringer receive tentative approval for diabetes drug

Eli Lilly and Company and Boehringer Ingelheim have received tentative approval from the FDA for Basaglar, indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients ...
 Individual.com4 days ago Boehringer and Eli Lilly receive FDA approval for type 2 diabetes drug  Individual.com1 week ago

Eli Lilly, Takeda To Pay $9 Billion In Punitive Damages

Eli Lilly and Takeda were not able to overturn the $9 billion in punitive damages they were ordered to pay for hiding the cancer risks associated with their Type II diabetes drug, Actos. Eli Lilly could sidestep its portion of the punishment, thanks ...
 Bidness Etc3 days ago Takeda, Eli Lilly fail to overturn US jury award of $9 billion in damages over Actos  FirstWord Pharma3 days ago Takeda, Eli Lilly fail in bid to reverse US jury award of $9 billion in damages over Actos  FirstWord Pharma2 days ago

Mylan A Tough Contender In The Biosimilar Anti-Diabetes Race

Mylan is going head-to-head with other pharmaceutical giants like Eli Lilly and Merck in competing to launch a biosimilar of Sanofi\\'s drug Lantus, which is expected to go off-patent by early 2015 Page 1 of 2 Published: August 29, 2014 at ...
 Bidness Etc3 days ago

Shares of Eli Lilly Rank the Highest in Terms of PEG Ratio in the Pharmaceuticals Industry (LLY, PFE, TEVA, MRK, NVS)

(Comtex SmarTrend(R)) Below are the three companies in the Pharmaceuticals industry with the highest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, ...
 Individual.com3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less